Polyamine/DNA polyplexes with acid-degradable polymeric shell as structurally and functionally virus-mimicking nonviral vectors.

Improving low transfection efficiency associated with nonviral vectors is crucial to utilize their advantages (e.g., low safety and manufacturing concerns) over viral vectors. Bioavailable polyamines (e.g., protamine sulfate [PS] and spermine [SPM]), attractively interact with nucleic acids but usually result in low transfection efficiency due to poor intracellular processes and limited complexation capability. In this study, PS/DNA and SPM/DNA polyplexes were shelled with an acid-degradable polyketal (PK) layer via surface-initiated photopolymerization. The resulting polyamine/PK core-shell nanoparticles have gene-carrying polyamine/DNA polyplex core shielded by PK shell, mimicking a viral vector consisting the gene-carrying capsid core and an outer envelope. The PK shell hydrolyzes at an endosomal pH, exposing the polyplex core that is further disassembled by heparan sulfate. Significantly enhanced transfection efficiency by the polyamine/PK core-shell nanoparticles, compared with that of corresponding polyamine/DNA polyplexes, was achieved. Confocal microscopy revealed efficient DNA release from the PS/PK core-shell nanoparticles into the nucleus and substantially increased cellular uptake of SPM/PK core-shell nanoparticles. In addition, lyophilized polyamine/PK core-shell nanoparticles showed preserved transfection capability. In conclusion, addition of an acid-degradable PK shell significantly improved cellular internalization and intracellular trafficking of polyamine/DNA polyplexes, resulting in enhanced transfection.

[1]  Kinam Park,et al.  Polycation gene delivery systems: escape from endosomes to cytosol , 2003, The Journal of pharmacy and pharmacology.

[2]  H. Harashima,et al.  Evaluation of nuclear transfer and transcription of plasmid DNA condensed with protamine by microinjection: The use of a nuclear transfer score , 2005, FEBS letters.

[3]  J. Cunningham,et al.  Retroviral Entry Mediated by Receptor Priming and Low pH Triggering of an Envelope Glycoprotein , 2000, Cell.

[4]  S. Kawakami,et al.  Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide. , 2008, Journal of pharmaceutical sciences.

[5]  S. Standley,et al.  Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses. , 2005, Molecular pharmaceutics.

[6]  D. W. Pack,et al.  A top-down approach for construction of hybrid polymer-virus gene delivery vectors. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[7]  J. Seelig,et al.  High affinity of the cell-penetrating peptide HIV-1 Tat-PTD for DNA. , 2007, Biochemistry.

[8]  Eric Perouzel,et al.  Nuclear Localisation Sequence Templated Nonviral Gene Delivery Vectors: Investigation of Intracellular Trafficking Events of LMD and LD Vector Systems , 2003, Chembiochem : a European journal of chemical biology.

[9]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[10]  S. L. Hyatt,et al.  Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. , 2004, Human gene therapy.

[11]  Shiroh Futaki,et al.  Evaluation of the nuclear delivery and intra‐nuclear transcription of plasmid DNA condensed with µ (mu) and NLS‐µ by cytoplasmic and nuclear microinjection: a comparative study with poly‐L‐lysine , 2006 .

[12]  Yaping Li,et al.  A smart nanoassembly consisting of acid-labile vinyl ether PEG-DOPE and protamine for gene delivery: preparation and in vitro transfection. , 2008, Biomacromolecules.

[13]  L. Huang,et al.  Protamine sulfate enhances lipid-mediated gene transfer , 1997, Gene Therapy.

[14]  Alan E. Smith,et al.  PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. , 1999, Human gene therapy.

[15]  A. Fahr,et al.  Nuclear Transport of Oligonucleotides in HepG2-cells Mediated by Protamine Sulfate and Negatively Charged Liposomes , 2000, Pharmaceutical Research.

[16]  A. El-Aneed,et al.  An overview of current delivery systems in cancer gene therapy. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[17]  J. Behr,et al.  Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture. , 2001, Journal of the American Chemical Society.

[18]  Daniel W. Pack,et al.  Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.

[19]  S Moein Moghimi,et al.  A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  Leaf Huang,et al.  Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.

[21]  D. W. Pack,et al.  A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. , 2003, Bioconjugate chemistry.

[22]  N. Minakawa,et al.  No enhancement of nuclear entry by direct conjugation of a nuclear localization signal peptide to linearized DNA. , 2003, Bioconjugate chemistry.

[23]  Felix Kratz,et al.  Polymer therapeutics: concepts and applications. , 2006, Angewandte Chemie.

[24]  C. Ropert.  Liposomes as a gene delivery system. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[25]  W. Song,et al.  Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors. , 1997, Human gene therapy.

[26]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Jianzhu Chen,et al.  Cross-linked Small Polyethylenimines: While Still Nontoxic, Deliver DNA Efficiently to Mammalian Cells in Vitro and in Vivo , 2005, Pharmaceutical Research.

[28]  D. Schaffer,et al.  PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. , 2005, Biotechnology and bioengineering.

[29]  S. Otto,et al.  Controlling the biological effects of spermine using a synthetic receptor. , 2006, Journal of the American Chemical Society.

[30]  K. Kogure,et al.  Multifunctional envelope-type nano device for non-viral gene delivery: concept and application of Programmed Packaging. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[31]  T. Yamauchi,et al.  Photografting of polymers onto nanosized silica surface initiated by eosin moieties immobilized onto the surface , 2005 .

[32]  A. Johnson,et al.  Polymerization of vinyl acetate using visible radiation and a dye-reducing agent sensitizer: 1. Pre-initiation and initiation reactions involving ethyl eosin and ascorbic acid , 1984 .

[33]  N. Murthy,et al.  Cross-linked microparticles as carriers for the delivery of plasmid DNA for vaccine development. , 2004, Bioconjugate chemistry.

[34]  Young Jik Kwon,et al.  Acid-degradable cationic methacrylamide polymerized in the presence of plasmid DNA as tunable non-viral gene carrier. , 2008, Biomaterials.

[35]  Do Young Yoon,et al.  A composite gene delivery system consisting of polyethylenimine and an amphipathic peptide KALA , 2006, The journal of gene medicine.

[36]  D W Pack,et al.  Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Hadley D Sikes,et al.  Visual detection of labeled oligonucleotides using visible-light-polymerization-based amplification. , 2008, Biomacromolecules.

[38]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[39]  I. S. Blagbrough,et al.  Polyamines and novel polyamine conjugates interact with DNA in ways that can be exploited in non-viral gene therapy. , 2003, Biochemical Society transactions.

[40]  J. Hagstrom,et al.  Layer-by-layer deposition of oppositely charged polyelectrolytes on the surface of condensed DNA particles. , 1999, Nucleic acids research.

[41]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[42]  A. Beaudet,et al.  Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. , 1997, Human gene therapy.

[43]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[44]  A. Graessmann,et al.  Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals. , 2002, Biochemistry.

[45]  Shiroh Futaki,et al.  Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[46]  C. Bowman,et al.  Polymerization Behavior and Polymer Properties of Eosin-Mediated Surface Modification Reactions. , 2008, Polymer.

[47]  M. Rots,et al.  A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. , 2004, Human gene therapy.

[48]  R. Hughes.  Strategies for cancer gene therapy , 2004, Journal of surgical oncology.

[49]  K. Kataoka,et al.  pH-responsive three-layered PEGylated polyplex micelle based on a lactosylated ABC triblock copolymer as a targetable and endosome-disruptive nonviral gene vector. , 2006, Bioconjugate chemistry.

[50]  J. Young,et al.  Two Retroviral Entry Pathways Distinguished by Lipid Raft Association of the Viral Receptor and Differences in Viral Infectivity , 2003, Journal of Virology.

[51]  G. Melikyan,et al.  HIV Enters Cells via Endocytosis and Dynamin-Dependent Fusion with Endosomes , 2009, Cell.

[52]  Qian-chun Yu,et al.  Utility of PEGylated recombinant adeno-associated viruses for gene transfer. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[53]  Ernst Wagner,et al.  Optimizing targeted gene delivery: Chemical modification of viral vectors and synthesis of artificial virus vector systems , 2006, The AAPS Journal.

[54]  L. Seymour,et al.  Key issues in non-viral gene delivery: Adv Drug Deliv Rev , 1998 .

[55]  J. Benoit,et al.  Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. , 2008, Biomaterials.

[56]  A. Jurado,et al.  Controlling the morphology in DNA condensation and precipitation. , 2009, Biomacromolecules.

[57]  L. Seymour,et al.  Key issues in non-viral gene delivery. , 1998, Advanced drug delivery reviews.

[58]  R. Mulligan,et al.  The basic science of gene therapy. , 1993, Science.

[59]  A. Klibanov,et al.  Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Ogris,et al.  PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery , 1999, Gene Therapy.

[61]  M. Ogris,et al.  Acetal linked oligoethylenimines for use as pH-sensitive gene carriers. , 2008, Bioconjugate chemistry.